Repligen Corporation | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (29)

View All

Latest Posts

About This Stock More About This Stock
Is It Too Late To Buy Moderna Stock?
Article By: Money Morning
Thursday, July 29, 2021 4:34 AM EDT
Moderna Inc. stock skyrocketed last year, moving over 434% on global demand for coronavirus vaccines. The question now is whether it can continue to rally higher, with or without COVID-19.
In this article: RGEN, MRNA Also: JNJ, PFE
Read
Regeneron To Collaborate With Roche For Global Supply Of Its Coronavirus Treatment
Article By: Benzinga
Wednesday, August 19, 2020 7:20 AM EDT
Regeneron Pharmaceuticals Inc and Roche Holding AG on Monday disclosed that they are collaborating to develop, manufacture, and distribute the former's COVID-19 antibody cocktail.
In this article: RHHBY, RGEN
Read
Four Stocks To Watch As The Race For A Coronavirus Vaccine Picks Up
Article By: Matt Weller
Tuesday, February 25, 2020 11:21 AM EDT
The rapid spread of coronavirus and the potential for global economic disruption led to the worst day for US stocks in two years yesterday.
In this article: JNJ, GILD, RGEN, MRNA Also: ZM
Read
5 Biotech Stocks To Buy Right Now
Article By: Zacks Investment Research
Tuesday, June 4, 2019 11:45 AM EDT
The biotech sector has had a rough past few weeks with many stocks hitting their lowest levels since January. That being said, here are five stocks that have outperformed their peers and are expected to have continued growth.
In this article: RGEN, ILMN, GILD, TECH, VRTX
Read
9 Monster Stock Market Predictions For The Week Of January 21
Article By: Michael J. Kramer
Monday, January 21, 2019 5:21 AM EDT
It will be a short trading week with Monday closed for Martin Luther King Jr. day. It will also be a relatively light week for economic data in the U.S.. with the Markit Manufacturing and Services PMI’s on Thursday.
In this article: QQQ, XLK, SPX, XLI, XLY, AAPL, MSFT, NFLX, TSLA, MU, ROKU, RGEN
Read
All Posts

Latest Tweets for $RGEN

No tweets yet!

PARTNER HEADLINES